|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.006 AUD | -25.00% |
|
-33.33% | -45.45% |
| Apr. 18 | Bioxyne to Raise AU$1.45 Million via Share Issuance | MT |
| Feb. 29 | Bioxyne Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Bioxyne Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported net loss was AUD 0.236508 million compared to AUD 0.495725 million a year ago. Basic loss per share from continuing operations was AUD 0.0004 compared to AUD 0.0008 a year ago.
Diluted loss per share from continuing operations was AUD 0.0004 compared to AUD 0.0008 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -45.45% | 7.97M | |
| +0.17% | 42.19B | |
| +10.92% | 42.24B | |
| +44.30% | 40.15B | |
| -6.20% | 28.31B | |
| +5.23% | 24.63B | |
| -24.79% | 18.2B | |
| +26.69% | 12.01B | |
| -3.13% | 11.76B | |
| +6.57% | 10.4B |
BIOXYNE LIMITED 
